🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

CHina Adrenal Venous saMPling InvestigatiON

Recruitingn/aAges 18 Years - anyAllChinese Academy of Medical Sciences, Fuwai Hospit…
NCT07252284 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Primary aldosteronism (PA) is a major cause of secondary hypertension, yet its optimal diagnosis and management remain challenging. This study comprehensively evaluates adrenal venous sampling (AVS), addressing key clinical, technical, and methodological issues, and aims to clarify the relationship between AVS-guided management and long-term clinical and biochemical outcomes to optimize patient care and prognosis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients with confirmed primary aldosteronism; 2. Patients undergoing adrenal venous sampling for subtype classification of primary aldosteronism. Exclusion Criteria: 1. Severe comorbidity, including stroke, myocardial infarction, heart failure, severe valvular heart disease, liver cirrhosis, and metastatic tumor within the previous 3 months； 2. An estimated glomerular filtration rate \<45 ml/min/1.73 m2, or serum creatinine \>176 μmol/L； 3. Patients who refuse adrenalectomy; 4. Suspected of having an adrenocortical carcinoma; 5. Allergy to contrast agent; 6. Pregnant, nursing, or planning to become pregnant
💊

What it tests

  • adrenal venous sampling
📍

Where

76 sites
The first affiliated hospital of USTC
Hefei, China
Chuiyangliu Hospital affiliated to Tsinghua University
Beijing, China
China-Japan Friendship Hospital
Beijing, China
Peking University First Hospital
Beijing, China
Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, China
Peking University People's Hospital
Beijing, China
Beijing Luhe Hospital, Capital Medical University
Beijing, China
Chongqing University Central Hospital
Chongqing, China

…and 68 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy